VHB Life Sciences

Mumbai, India Founded: 1946 • Age: 80 yrs
Generics and APIs are manufactured across therapeutic segments.
Annual revenue $16.3M Latest available
Total funding - Funding intelligence
Employees 280 Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors - Brand Intelligence

About VHB Life Sciences

VHB Life Sciences is a company based in Mumbai (India) founded in 1946. The company has 280 employees as of April 05, 2025. VHB Life Sciences offers products and services including Anti-Cancer Drugs, Anti-Infective Drugs, General Injectables, and Hormones.

  • Headquarter Mumbai, India
  • Employees 280 as on 05 Apr, 2025
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Vhb Medi Sciences Limited
  • Jurisdiction Kandivlai West, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $16.33 M (USD)
    12.68
    as on Mar 31, 2024
  • Net Profit
    $1.06 M (USD)
    -27.69
    as on Mar 31, 2024
  • EBITDA
    $2.53 M (USD)
    -1.67
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    280

    as on Apr 05, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of VHB Life Sciences

VHB Life Sciences offers a comprehensive portfolio of products and services, including Anti-Cancer Drugs, Anti-Infective Drugs, General Injectables, and Hormones.

Product name locked
Category locked
Primary

Treatments for cancer and related conditions

Product name locked
Category locked
Locked

Medications to combat bacterial and viral infections

Product name locked
Category locked
Locked

Injectable formulations for various medical applications

Product name locked
Category locked
Locked

Hormonal treatments for endocrine and related disorders

Funding Insights of VHB Life Sciences

Premium access

Detailed funding history for VHB Life Sciences

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by VHB Life Sciences

Investments
Premium access

Investment portfolio details for VHB Life Sciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - VHB Life Sciences

Premium access

Detailed financials for VHB Life Sciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Vhb Life Sciences Comparisons

VHB Life Sciences Primary company
Description
Generics and APIs are manufactured across therapeutic segmen...
Location
Mumbai, India
Founded Year
1946
Annual Revenue
$16.33 M (USD)
Net Profit
$1.06 M (USD)
EBITDA
$2.53 M (USD)
Employees
280
As of 2025
Premium access

Peer comparison for VHB Life Sciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of VHB Life Sciences

Premium access

Detailed competitors of VHB Life Sciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Vhb Life Sciences

Premium access

Complete news archive for VHB Life Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about VHB Life Sciences

VHB Life Sciences was founded in 1946.

VHB Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Apr 05, 2025, the latest employee count at VHB Life Sciences is 280.

Annual revenue of VHB Life Sciences is $16.33M as on Mar 31, 2024.

VHB Life Sciences was founded in 1946 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where branded generics and active pharmaceutical ingredients are produced and marketed. Coverage includes multiple therapeutic areas such as cardiology, immunology, oncology, neurology, nephrology, gynecology, and paediatric care. The company serves domestic and international markets through its manufacturing facilities.

VHB Life Sciences offers Anti-Cancer Drugs, Anti-Infective Drugs, General Injectables, and Hormones.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available